BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The net proceeds will be used to purchase gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offer Details
Shares of common stock are being offered through an underwritten public offering.
Use of Proceeds
Proceeds will be used to purchase gold bullion, working capital, and general corporate purposes.
Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
- BioSig Technologies aims to raise capital through this public offering to support its investment policy and corporate activities.
- The successful completion of this offering will provide the company with resources to further its strategic objectives.
The announcement of the proposed public offering signifies BioSig Technologies' strategic move towards strengthening its financial position and pursuing its investment policy. With Clear Street and Needham & Company as the managers, the company aims to utilize the proceeds for gold purchases and general corporate purposes.